Status:
UNKNOWN
Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Lead Sponsor:
Ospedale Santa Croce-Carle Cuneo
Conditions:
Hematological Diseases
Invasive Aspergillosis
Eligibility:
All Genders
16+ years
Brief Summary
Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan...
Eligibility Criteria
Inclusion
- Age \> 16 years
- Allogeneic HSCT for a haematological disease
- Written informed consent to the study
Exclusion
- Pediatric patients
Key Trial Info
Start Date :
May 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00838643
Start Date
May 1 2002
End Date
December 1 2009
Last Update
February 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Sanitaria Ospedaliera santa Croce e Carle
Cuneo, Italy, 12100